Skip to main content
. 2011 Aug 9;118(16):4346–4352. doi: 10.1182/blood-2011-01-330738

Table 3.

Results of full-dose compared with intermediate-dose melphalan

Melphalan dose 200 mg/m2 (N = 231) Melphalan dose 100-140 mg/m2 (N = 190) P
CR rate, % 42.8 24.2 < .001*
TRM, % 9 14.2 .12*
Median EFS, months 40.9 21.3 .0006*
Median OS, y 8.4 3.8 < .0001*
*

Statistically significant.

HHS Vulnerability Disclosure